• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Eph 受体及其配体在视网膜疾病中的作用

Eph Receptors and Ephrins in Retinal Diseases.

机构信息

Department of Ophthalmology, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, 50-556 Wroclaw, Poland.

出版信息

Int J Mol Sci. 2021 Jun 8;22(12):6207. doi: 10.3390/ijms22126207.

DOI:10.3390/ijms22126207
PMID:34201393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8227845/
Abstract

Retinal diseases are the leading cause of irreversible blindness. They affect people of all ages, from newborns in retinopathy of prematurity, through age-independent diabetic retinopathy and complications of retinal detachment, to age-related macular degeneration (AMD), which occurs mainly in the elderly. Generally speaking, the causes of all problems are disturbances in blood supply, hypoxia, the formation of abnormal blood vessels, and fibrosis. Although the detailed mechanisms underlying them are varied, the common point is the involvement of Eph receptors and ephrins in their pathogenesis. In our study, we briefly discussed the pathophysiology of the most common retinal diseases (diabetic retinopathy, retinopathy of prematurity, proliferative vitreoretinopathy, and choroidal neovascularization) and collected available research results on the role of Eph and ephrins. We also discussed the safety aspect of the use of drugs acting on Eph and ephrin for ophthalmic indications.

摘要

视网膜疾病是导致不可逆性失明的主要原因。它们影响所有年龄段的人群,从早产儿视网膜病变中的新生儿,到与年龄无关的糖尿病性视网膜病变和视网膜脱离的并发症,再到主要发生在老年人中的年龄相关性黄斑变性(AMD)。一般来说,所有问题的原因都是血液供应紊乱、缺氧、异常血管的形成和纤维化。尽管它们的详细机制各不相同,但共同点是 Eph 受体和 Ephrins 参与了它们的发病机制。在我们的研究中,我们简要讨论了最常见的视网膜疾病(糖尿病性视网膜病变、早产儿视网膜病变、增生性玻璃体视网膜病变和脉络膜新生血管形成)的病理生理学,并收集了 Eph 和 Ephrins 作用的现有研究结果。我们还讨论了作用于 Eph 和 Ephrins 的药物用于眼科适应症的安全性方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/3cce58956fe6/ijms-22-06207-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/da66e8f1a4ca/ijms-22-06207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/b520b4639016/ijms-22-06207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/50a891e8c959/ijms-22-06207-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/b6e13ad51427/ijms-22-06207-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/4d0d9ede30e6/ijms-22-06207-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/3cce58956fe6/ijms-22-06207-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/da66e8f1a4ca/ijms-22-06207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/b520b4639016/ijms-22-06207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/50a891e8c959/ijms-22-06207-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/b6e13ad51427/ijms-22-06207-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/4d0d9ede30e6/ijms-22-06207-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/469a/8227845/3cce58956fe6/ijms-22-06207-g006.jpg

相似文献

1
Eph Receptors and Ephrins in Retinal Diseases.Eph 受体及其配体在视网膜疾病中的作用
Int J Mol Sci. 2021 Jun 8;22(12):6207. doi: 10.3390/ijms22126207.
2
Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis.Ephrins 和 Eph 受体信号在组织修复和纤维化中的作用。
Curr Rheumatol Rep. 2019 Apr 12;21(6):23. doi: 10.1007/s11926-019-0825-x.
3
Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.血管通透性在视网膜病变中受 VEGFR2 Y949 信号调节至 VE-钙黏蛋白。
Elife. 2020 Apr 21;9:e54056. doi: 10.7554/eLife.54056.
4
Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration.促红细胞生成素/红细胞生成素受体与兴奋性氨基酸受体之间的相互作用:在突触可塑性调节及神经元变性病理生理学中的潜在关联。
J Neurochem. 2006 Jul;98(1):1-10. doi: 10.1111/j.1471-4159.2006.03844.x.
5
Ephrin-Eph signaling usage by a variety of viruses.多种病毒对 Ephrin-Eph 信号的利用。
Pharmacol Res. 2020 Sep;159:105038. doi: 10.1016/j.phrs.2020.105038. Epub 2020 Jun 18.
6
Eph receptors and ephrins in cancer: bidirectional signalling and beyond.Eph 受体及其配体在癌症中的作用:双向信号传递及其他。
Nat Rev Cancer. 2010 Mar;10(3):165-80. doi: 10.1038/nrc2806.
7
The role of ephrins and Eph receptors in cancer.Ephrin 与 Eph 受体在癌症中的作用。
Cytokine Growth Factor Rev. 2004 Dec;15(6):419-33. doi: 10.1016/j.cytogfr.2004.09.002.
8
Eph-ephrin bidirectional signaling in physiology and disease.Eph-ephrin在生理与疾病中的双向信号传导
Cell. 2008 Apr 4;133(1):38-52. doi: 10.1016/j.cell.2008.03.011.
9
Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.非诺贝特抑制细胞色素P450环氧化酶2C活性以抑制病理性眼部血管生成。
EBioMedicine. 2016 Nov;13:201-211. doi: 10.1016/j.ebiom.2016.09.025. Epub 2016 Sep 30.
10
Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.大鼠脂多糖发热期间Eph受体及其配体ephrins的表达
Physiol Genomics. 2005 Apr 14;21(2):152-60. doi: 10.1152/physiolgenomics.00043.2004. Epub 2005 Jan 25.

引用本文的文献

1
Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications.视网膜疾病中的纳米技术:从疾病诊断到治疗应用。
Biophys Rev (Melville). 2024 Nov 5;5(4):041305. doi: 10.1063/5.0214899. eCollection 2024 Dec.
2
Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components.糖尿病视网膜病变中的微血管不稳定与细胞因子的复杂网络:从细胞和分子成分的角度来看
Cell Biosci. 2024 Jun 27;14(1):85. doi: 10.1186/s13578-024-01269-7.
3
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway.

本文引用的文献

1
Inhibition of laser induced rats choroidal neovascularization by intravitreous injection of sEphB4-HSA.玻璃体内注射sEphB4-HSA对激光诱导的大鼠脉络膜新生血管形成的抑制作用
Ann Transl Med. 2021 Jan;9(1):18. doi: 10.21037/atm-20-3810.
2
Ephrin-A5 Is Involved in Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.Ephrin-A5 参与氧诱导视网膜病变小鼠模型中的视网膜新生血管化。
Biomed Res Int. 2020 Oct 10;2020:7161027. doi: 10.1155/2020/7161027. eCollection 2020.
3
Pericyte-Endothelial Interactions in the Retinal Microvasculature.
青蒿琥酯通过抑制 Stat3/Akt 信号通路抑制 EFNA3 从而抑制脉络膜黑色素瘤的发生。
J Cancer Res Clin Oncol. 2024 Apr 17;150(4):202. doi: 10.1007/s00432-024-05711-8.
4
EphB1 causes retinal damage through inflammatory pathways in the retina and retinal Müller cells.EphB1 通过视网膜和视网膜 Müller 细胞中的炎症途径引起视网膜损伤。
Mol Vis. 2024 Mar 22;30:167-174. eCollection 2024.
5
Ephrin B1 Regulates Inflammatory Pathways in Retinal Müller Cells.Ephrin B1调节视网膜穆勒细胞中的炎症通路。
J Diabetes Clin Res. 2024;6(1):1-7. doi: 10.33696/diabetes.6.056.
6
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.SARS-CoV-2 的结构蛋白和非结构蛋白:COVID-19 治疗或预防相关疾病进展的潜在方面。
Cell Commun Signal. 2023 May 15;21(1):110. doi: 10.1186/s12964-023-01104-5.
7
Effects of L. Polysaccharides on Vascular Retinopathy: An Insight Review.L. 多糖对血管性视网膜病变的影响:综述性洞察。
Molecules. 2022 Aug 31;27(17):5628. doi: 10.3390/molecules27175628.
8
Roles of Eph-Ephrin Signaling in the Eye Lens Cataractogenesis, Biomechanics, and Homeostasis.Eph-Ephrin信号通路在晶状体白内障形成、生物力学及内环境稳定中的作用
Front Cell Dev Biol. 2022 Feb 28;10:852236. doi: 10.3389/fcell.2022.852236. eCollection 2022.
周细胞-内皮细胞相互作用在视网膜微血管中的作用。
Int J Mol Sci. 2020 Oct 8;21(19):7413. doi: 10.3390/ijms21197413.
4
Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients.糖尿病视网膜病变患者队列中的血浆 Ephrin-A1 水平。
BMC Ophthalmol. 2020 Aug 5;20(1):319. doi: 10.1186/s12886-020-01580-0.
5
Approaches to Manipulate Ephrin-A:EphA Forward Signaling Pathway.操纵 Ephrin-A:EphA 正向信号通路的方法。
Pharmaceuticals (Basel). 2020 Jun 30;13(7):140. doi: 10.3390/ph13070140.
6
Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents.周细胞中 Ephrin-B2 表达增加导致啮齿动物视网膜血管死亡。
Vascul Pharmacol. 2020 Aug;131:106761. doi: 10.1016/j.vph.2020.106761. Epub 2020 Jun 22.
7
The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.EphrinB2/EphB4 与 VEGF 的相互作用在血管生成诱导中的关键作用。
Mol Biol Rep. 2020 Jun;47(6):4681-4690. doi: 10.1007/s11033-020-05470-y. Epub 2020 Jun 2.
8
Antibody Targeting of Eph Receptors in Cancer.癌症中Eph受体的抗体靶向作用
Pharmaceuticals (Basel). 2020 May 8;13(5):88. doi: 10.3390/ph13050088.
9
Induced Expression of VEGFC, ANGPT, and EFNB2 and Their Receptors Characterizes Neovascularization in Proliferative Diabetic Retinopathy.诱导 VEGFC、ANGPT 和 EFNB2 的表达及其受体特征性地标记增生型糖尿病视网膜病变中的新生血管形成。
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4084-4096. doi: 10.1167/iovs.19-26767.
10
Molecular complexity of visual mapping: a challenge for regenerating therapy.视觉映射的分子复杂性:再生治疗面临的一项挑战。
Neural Regen Res. 2020 Mar;15(3):382-389. doi: 10.4103/1673-5374.266044.